Marketing-authorisation holder · United States
Assertio Speclty
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CAMBIA50mg · For solution | Diclofenac | United States | Marketed | 2009 |
| OTREXUP10mg/0.4ml (10mg/0.4ml) | 12.5mg/0.4ml (12.5mg/0.4ml) | 15mg/0.4ml (15mg/0.4ml) | 17.5mg/0.4ml (17.5mg/0.4ml) | 20mg/0.4ml (20mg/0.4ml) | 22.5mg/0.4ml (22.5mg/0.4ml) | 25mg/0.4ml (25mg/0.4ml) | 7.5mg/0.4ml (7.5mg/0.4ml) · Solution | Methotrexate | United States | Not marketed | 2013 |
| OTREXUP PFS10mg/0.4ml (10mg/0.4ml) | 15mg/0.6ml (15mg/0.6ml) | 17.5mg/0.7ml (17.5mg/0.7ml) | 20mg/0.8ml (20mg/0.8ml) | 22.5mg/0.9ml (22.5mg/0.9ml) | 25mg/ml (25mg/ml) · Solution | Methotrexate | United States | Not marketed | 2013 |
| SYMPAZAN10mg | 20mg | 5mg · Film | Clobazam | United States | Marketed | 2018 |
| ZIPSOR25mg · Capsule | Diclofenac | United States | Marketed | 2009 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 5 |